Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01658787 · ClinicalTrials.gov registry record
Global Registry for Endovascular Aortic Treatment (GREAT)
A clinical trial of Multiple Pathologies, sponsored by W.L.Gore & Associates.
- Active
- Registry status
- 4,600
- Enrollment target
- 6
- Study locations
NCT01658787 is a study of Multiple Pathologies that is active but no longer recruiting, run by W.L.Gore & Associates. The registered enrollment target is 4,600 participants. The trial reports 6 study locations across 4 states.
The verdict
NCT01658787, a study of Multiple Pathologies, is active but no longer recruiting, sponsored by W.L.Gore & Associates.
- ACTIVE NOT RECRUITING
- Registry status
- 4,600 participants
- Enrollment target
- 6
- Study locations
Study Summary
Prospective, observational Registry to obtain data on device performance and clinical outcomes.
Conditions Studied
Interventions
- DEVICE Endovascular aortic repair
Study Locations (6)
Other
- Coris Medicina Avançada - Florianópolis
- Fondazione IRCCS Ca Granda Ospedale Maggiore Policlinico - Milan
- IRCCS Policlinico San Donato - Milan
Illinois
- The University of Chicago Medicine & Biological Sciences - Chicago
Texas
- Baylor Research Institute - Plano
New South Wales
- Royal Prince Alfred Hospital - Camperdown
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4,600 participants |
| Start Date | 2010-12 |
| Est. Completion | 2027-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01658787
The ClinicalTrials.gov registry entry for NCT01658787 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 4,600 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is W.L.Gore & Associates, which has 53 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Multiple Pathologies appearing as the primary indexed condition, and to 1 intervention - of which Endovascular aortic repair is the first listed.
NCT01658787 reports 6 study locations spanning 4 distinct geographic areas - top geographies include Other, Illinois, Texas.
Frequently Asked Questions
What is clinical trial NCT01658787 about?
NCT01658787 is a clinical study titled "Global Registry for Endovascular Aortic Treatment (GREAT)". Prospective, observational Registry to obtain data on device performance and clinical outcomes.
What is the current status of trial NCT01658787?
This trial is currently active not recruiting. The enrollment target is 4,600 participants. The study started on 2010-12. Estimated completion is 2027-06.
What conditions does trial NCT01658787 study?
This clinical trial studies the following conditions: Multiple Pathologies.
What interventions are being tested in trial NCT01658787?
The interventions under investigation include: Endovascular aortic repair (DEVICE).
Who is sponsoring clinical trial NCT01658787?
This trial is sponsored by W.L.Gore & Associates, which has 53 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01658787 being conducted?
This trial has 6 study locations across Illinois, Texas, New South Wales. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.